<DOC>
	<DOCNO>NCT01500941</DOCNO>
	<brief_summary>Probiotics suggest beneficial effect atopic dermatitis ( AD ) treatment prevention precise role yet clear . The aim randomize double blind active treatment v placebo study evaluate clinical efficacy intake combination two probiotic ( Lactobacillus salivarius LS01 Bifidobacterium breve BR03 ) treatment adult AD patient . The rationale use probiotic treatment atopic dermatitis would due experimental hypothesis : 1 . The use microbial agent early age seem play important role induce immunity T type 1 ( Th1 ) inhibit development Th2 response IgE mediate 2. normal intestinal flora ( include probiotic ) would play important role induce immunological tolerance 3. hygiene hypothesis reduce bacterial environment would favour type 2 response T development allergic disease</brief_summary>
	<brief_title>Probiotics Adults : They Improve Atopic Dermatitis ?</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>Adults age 1855 year Diagnosis DA moderate / severe , assess use standardized index severity AD ( SCORAD = Scoring Atopic Dermatitis index ) ( 42 ) , prepared European Task Force atopic dermatitis Allergic contact dermatitis ( ACD ) , active In absence know food allergy elimination diet Chronic disease ( autoimmune disease , COPD , heart disease , IRC , CNS disease , chronic gastrointestinal disease , diabetes , congenital acquire immunosuppression ) Pregnancy / lactation Treatment probiotic 6 month precede enrollment Treatment steroid antihistamine systemically three month prior enrollment Topical treatment immunomodulators ( tacrolimus pimecrolimus ) three month prior enrollment Acute chronic infectious disease Preexisting hypersensitivity component contain probiotic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>